A phase 1b trial to evaluate safety and effect of SAR443122 on immune system in severe COVID-19

Trial Identifier: PDY16879
Sponsor: sanofi
Start Date: July 2020
Primary Completion Date: October 2020
Study Completion Date: October 2020
Condition: Coronavirus Infection

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
ARGENTINA Caba, ARGENTINA, 1430
BRAZIL Porto Alegre, BRAZIL, 90035 003
BRAZIL São José Do Rio Preto, BRAZIL, 15090-000
BRAZIL São Paulo, BRAZIL, 04321-120
CHILE Santiago, CHILE, 8900085
CHILE Santiago, CHILE, 750-0691
CHILE Talca, CHILE, 3460001
MEXICO Monterrey, MEXICO, 64460
RUSSIAN FEDERATION Moscow, RUSSIAN FEDERATION, 123182
RUSSIAN FEDERATION Moscow, RUSSIAN FEDERATION, 111539